• OZARELIX chembl:CHEMBL2108312 Antineoplastic

    Alternate Names:

    OZARELIX
    D-63153

    Drug Info:

    FDA Approval not approved
    Drug Class peptide
    Drug Indications antineoplastic agent
    (0 More Sources)

    Publications:

  • Interaction Score: 3.86

    Interaction Types & Directionality:
    n/a

    Interaction Info:
    Novel drug target Established target
    Trial Name SPI-153, D-63153,Ozarelix

    PMIDs:
    None found


    Sources:
    TdgClinicalTrial

  • Interaction Score: 3.09

    Interaction Types & Directionality:
    antagonist (inhibitory)

    Interaction Info:
    Mechanism of Interaction Gonadotropin-releasing hormone receptor antagonist
    Direct Interaction yes
    Trial Name SPI-153, D-63153,Ozarelix

    PMIDs:
    None found